Ph.D. from Dalhousie University, Canada, postdoctoral fellow in Harvard Medical School in the USA. Dr. Fang is a veteran drug researcher and entrepreneur. He is the founder, CEO and CSO of RemeGen. He is also the founder of MabPlex International. Dr. Fang is a professor at Tongji University in Shanghai and has more than 40 invention patents related to therapeutic development. He is the inventor of conbercept, an innovative biologics approved in China for ophthalmology indications.